BEYOND COMPLIANCE

The Regulatory Path Is a Business Decision Before It Is a Submission Decision

A regulatory pathway is often treated as a technical classification exercise. In practice, it can determine evidence burden, supplier responsibilities, claims flexibility, launch timing, cost and the commercial model itself.

That means the right question is not simply, “Which route can we file?” The stronger question is, “Which route can our evidence, product strategy and operating model actually defend?”

The Expensive Mistake Happens Before the Submission

By the time a submission package is assembled, many business assumptions may already be locked: intended use, product claims, supplier contracts, labeling, development scope, validation expectations and launch commitments. If the pathway decision was weak, the rework is no longer just regulatory. It becomes operational and commercial.

A Defensible Pathway Must Survive Three Tests

• Regulatory fit: classification, intended use, claims and applicable requirements are coherent.
• Evidence fit: the available and planned evidence can support the route without filling critical gaps with assumptions.
• Business fit: the route is compatible with timing, supplier structure, commercial claims, resources and downstream obligations.

A route that passes only the first test may still be the wrong route for the business.

Make the Decision While It Is Still Cheap to Change

The best time to challenge the pathway is before evidence generation, supplier commitments and commercial promises make the decision expensive to reverse. A focused regulatory assessment should expose the assumptions, identify the evidence that matters and clarify the consequences of each viable route.